COMPENSATION TO THE BOARD OF DIRECTORS (AUDITED)

TABLE [4]: ANNUAL COMPENSATION TO THE BOARD OF DIRECTORS IN 2025 AND 2024

CHF 1,000Year

Fixed 

fee

Committee fee

Total cash compensation

Social benefits1

Share award plan: shares granted

(number)2

Fair value of shares granted3

Total 
compensation

Dr. Lukas Braunschweiler 
(Chairman)
2025200

-

200

15

291

48

263

2024200

-

200

17

253

82

299

Myra Eskes202580

33

113

10

131

22

145

202480

20

100

-

114

37

148

Dr. Oliver S. Fetzer202580

33

113

-

131

22

135

202480

23

103

-

114

37

140

Matthias Gillner202580

40

120

10

131

22

152

202480

30

110

11

114

37

158

Dr. Karen Huebscher4202527

7

34

5

131

22

61

202480

27

107

11

114

37

155

Dr. Christa Kreuzburg 202580

27

107

7

131

22

136

202480

40

120

9

114

37

166

Monica Manotas5202547

12

59

-

131

22

81

202453

13

66

-

-

-

66

Dr. Daniel R. Marshak
 
202580

27

107

-

131

22

129

202480

20

100

-

114

37

137

         
Total 2025674179853471,2082021,102
2024733173906599373041,269
  1. Employer’s contribution to social security.
  2. Vesting condition: Graded vesting from May 1, 2024 to April 30, 2025 (Share Plan BoD 2024) and from May 1, 2025 to April 30, 2026 (Share Plan BoD 2025). Vested shares are transferred at the end of the service period (April 30, 2025 and April 30, 2026, respectively). The shares are fully included in the amount of fair value of shares granted.
  3. Formula for 2024: Shares granted in 2024 * fair value at grant (CHF 325.60) and formula for 2025: Shares granted in 2025 * fair value at grant (CHF 165.00)
  4. Dr. Karen Hübscher's term as a member of the Board of Directors ended at the Annual General Meeting on April 18, 2025.
  5. Monica Manotas' membership in the Board of Directors ended on July 31, 2025 as she became CEO of Tecan on August 1, 2025.

At the 2024 Annual General Meeting, shareholders approved a maximum aggregate compensation amount of CHF 1,700,000 for the Board of Directors for the term from the 2024 Annual General Meeting until the 2025 Annual General Meeting. The actual compensation paid to the Board of Directors for 2025 was CHF 1,102,000. At the 2025 Annual General Meeting, shareholders confirmed the aggregate compensation amount of CHF 1,700,000 for the Board of Directors for the term from the 2025 Annual General Meeting until the 2026 Annual General Meeting. This compensation period is not completed yet and a conclusive assessment will be provided in the 2026 Compensation Report.

 

COMPENSATION TO THE MANAGEMENT BOARD (AUDITED)

COMPENSATION AT GRANT VALUE

The table [5] shows the compensation of the CEO and the other members of the Management Board granted in the reporting year.

 

TABLE [5]: GRANTED COMPENSATION

          Number of granted / awarded shares
CHF 1,000 (gross amounts)YearFixed Base SalaryTaxable fringe benefitsSocial 
benefits1
Short-term variable compen-­sation2Fair value of PSMP initial shares (in the year of grant)3Fair value of PSMP matching shares (in the year of grant)4

Total compen-sation 

(granted)

 PSMP: number of shares ­initial grantPSMP: number of matching shares (at factor 1.25)PSMP: number of matching shares (at maximum)

Dr. Achim von Leoprechting5

(former CEO)

2025

675

11

241

432

777

972

3,107

 

4,711

5,889

11,778

2024

675

11

296

136

850

1,063

3,031

 

2,611

3,264

6,528

Monica Manotas (CEO since August 1, 2025)62025

281

16

112

180

583

729

1,901

 

3,734

4,668

9,335

Tania Micki62024

398

12

174

52

416

520

1,572

 

1,277

1,596

3,193

Other members of the ­Management Board72025

2,675

234

934

1,102

2,259

2,824

10,027

 

13,690

17,114

34,228

2024

2,264

325

1,042

291

2,034

2,543

8,498

 

6,299

7,874

15,748

  

 

 

 

 

 

 

 

 

 

 

 

Total 2025

3,631

261

1,287

1,714

3,619

4,524

15,036

 

22,135

27,671

55,341

2024

3,337

348

1,512

479

3,300

4,126

13,101

 

10,187

12,734

25,468

  1. Employer's contribution to social security and contributions to post-employment benefit plans (including social security on shares transferred during the reporting period).
    2 Payment will be made in the following year.
    3 Formula for 2024: Shares granted in 2024 * fair value at grant (CHF 325.60).
    3 Formula for 2025: Shares granted in 2025 * fair value at grant (CHF 165.00). Exception: fair value at grant for Monica Manotas, who started effective August 1, 2025, was CHF 156.20.
    4 Formula for 2024: Shares granted in 2024 * fair value at grant (CHF 325.60) * 1.25. The disclosed amount corresponds to the fair value of the matching shares at the time of grant (e.g. based on performance achievement at target). This value may differ from the value of the accruals disclosed under IFRS reporting, as those are based on a best-estimate at the end of the reporting year.
    4 Formula for 2025: Shares granted in 2025 * fair value at grant (CHF 165.00) * 1.25. The disclosed amount corresponds to the fair value of the matching shares at the time of grant (e.g. based on performance achievement at target). This value may differ from the value of the accruals disclosed under IFRS reporting, as those are based on a best-estimate at the end of the reporting year. Exception: fair value at grant for Monica Manotas, who started effective August 1, 2025, was CHF 156.20.
    5 Member of the Management Board with the highest compensation in 2024 and 2025.
    6 Members of the Management Board with the second highest compensation in 2024 and 2025.
    7 2024: Total eight members. 2025: Total eight members. Figures for Other Members of the Management Board includes the values for the position of CFO, which was shown separately in 2024 as Member of the Management Board with the second highest compensation.

Explanatory comments on the compensation table:

Details for the achievement of targets for short-term variable cash compensation in 2024 are given below.

At the 2024 Annual General Meeting, shareholders approved a maximum aggregate compensation amount of CHF 20,500,000 for the Management Board for the financial year 2025. The actual compensation awarded to the Management Board in 2025 was CHF 15,036,000 and is therefore within the approved limits.

ILLUSTRATION [6]: COMPENSATION MIX

PERFORMANCE IN 2025

Reported sales for the Group for fiscal year 2025 decreased in comparison to fiscal year 2024 by 1.6% in local currencies, leading to a payout ratio of 84% for this component of the short-term variable cash compensation. The adjusted EBITDA target prior to tariffs and FX impacts was 17.8% and resulted in a payout ratio of 108% for this component. The sustainability objectives for cultural development, environmental impact and governance achieved a ratio of 95% combined for these targets. Details of the individual goals and target achievement levels are shared below.

 

GoalEnhancing Tecan’s working culture &
leadership competences
Results

Achievement Levels

Sub-Target 1Achieving an 82% participation rate in the
all-employee engagement survey.
Participation rate of 87% achieved.

Overachieved

Sub-Target 2Achieving a trust level index of 73%.The GPTW trust level index
was measured at 68%.

Not achieved

Sub-Target 3Achieving an inclusion level in the workforce
of 66%, through agreement with the statement
in the survey “Tecan is a psychologically and
emotionally healthy place to work.”
62% of participants agreed with the statement
"Tecan is a psychologically and emotionally
healthy place to work."

Not achieved

Final Rating

30%

GoalEnergy managementResults

Achievement Levels

Sub-Target 1Purchasing of 100% renewable electricity for
Tecan Group in 2025, the completion of energy
audits at sites collectively responsible for two
thirds of Tecan’s onsite energy consumption.
100% renewable electricity achieved, 5 audits
conducted at sites covering 74% of total energy
consumption.

Overachieved

Sub-Target 2

Setting an energy reduction target support-
ing Tecan's SBTI Scope 1 & 2 target 2030 and

to complete energy reduction activities and
communications.

Target set: Tecan commits to reduce its annual
energy consumption by 5% by 2030 compared
to 2024 baseline (like-for-like comparison).
25% of all non-CAPEX-related measures from
the energy audits were implemented in 2025.

A global Energy Efficiency Campaign plus dis-
tribution of a guideline in local languages was

launched. Reduction in emissions from energy
consumption compared to 2022 baseline
achieved.

Partially
overachieved

Final Rating

160%

The financial performance indicators were equally weighted and accounted for 80% of the short-term variable cash compensation, and the sustainability targets accounted for the remaining 20%. A detailed overview of the individual achievements relative to their set target is shown in illustration [7] below.

In the year under review, the 2023 to 2025 PSMP cycle came to an end. In the 2023 Annual Report the performance objectives for the three-year cycle 2023-2025 were disclosed prospectively, just as the current cycle is set out in table [2] above. The actual performance achievement over the performance period resulted in a matching share factor of 0. This reflects for the cycle 2023 to 2025 an average growth rate of minus 4% and an average adjusted EBITDA margin of 19%.

ILLUSTRATION [7]: 2025 SHORT-TERM INCENTIVE TARGET ACHIEVEMENT

COMPENSATION TO FORMER MEMBERS OF GOVERNING BODIES

No compensation was paid to former members of the Board of Directors or the Management Board in 2025 after the end of their term of office or contract with Tecan, respectively.

COMPENSATION TO RELATED PARTIES

No compensation was paid in 2025 or the previous year to parties related to present or former members of the Board of Directors or the Management Board.

LOANS AND CREDITS

CURRENT AND FORMER MEMBERS OF GOVERNING BODIES

Neither in 2025 nor in the previous year were any loans or credits extended to current or former members of the Board of Directors or the Management Board that remained outstanding at the end of the year.

 

RELATED PARTIES

Neither in 2025 nor in the previous year were any loans or credits extended to related parties of current or former members of the Board of Directors or the Management Board that remained outstanding at the end of the year.

SHAREHOLDINGS OF THE MEMBERS OF THE BOARD OF DIRECTORS AND THE MANAGEMENT BOARD IN 2025 (AUDITED)

SHARE AND OPTION OWNERSHIP OF THE BOARD OF DIRECTORS AND MANAGEMENT BOARD

For details of the employee participation plans please refer to note 12.4 of the consolidated financial statements.

TABLE [6]: SHARE AND OPTION OWNERSHIP OF THE BOARD OF DIRECTORS

 Year

Total options

Total shares

Number 

 

 

Dr. Lukas Braunschweiler (Chairman)2024

 – 

2,043

2025

– 

2,334

Myra Eskes2024

– 

229

2025

– 

360

Dr. Oliver S. Fetzer2024

– 

3,370

2025

– 

3,501

Matthias Gillner2024

– 

184

2025

– 

315

Dr. Karen Huebscher12024

– 

1,097

2025

– 

-

Dr. Christa Kreuzburg2024

– 

– 

2025

– 

131

Monica Manotas22024

– 

– 

2025

n.a. 

n.a.

Dr. Daniel R. Marshak
 
2024

– 

872

2025

– 

1,003

  

 

 

Balance at December 31, 2024 

 – 

7,795

Balance at December 31, 2025 

7,664

  1. The member did not stand for re-electon in 2025.
  2. The member moved from the Board of Directors to the Management Board in 2025.

TABLE [7]: SHARE AND OPTION OWNERSHIP OF THE MANAGEMENT BOARD

 Year

Total options

Total shares

Number 

 

 

Monica Manotas (CEO)12024

-

2025

– 

3,865

Dr. Achim von Leoprechting22024

– 

6,329

2025

– 

11,040

Tanja Micki (CEO)2024

-

3,309

2025

– 

5,717

Mukta Acharya2024

901 

708

2025

901 

2,383

Ralf Griebel22024

– 

2,515

2025

– 

4,164

Ulrich Kanter2024

– 

2,475

2025

– 

4,098

Erik Norström2024

– 

2,156

2025

– 

3,674

Ingrid Pürgstaller2024

– 

2,097

2025

– 

3,668

Andreas Wilhelm2024

– 

2,156

2025

– 

3,727

Dr. Wael Yared2024

– 

4,010

2025

– 

4,685

   

 

Balance at December 31, 2024 901

25,755

Balance at December 31, 2025 901

47,021

  1. The member moved from Board of Directors to the Management Board in 2025.
  2. The member is on garden leave. The employment will end in 2026.